ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

New NIH Grant Program or Young Investigators

October 8, 2010

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

Senate Bill Matches 42.01 Billion Bush request For NCI, Sets Bypass Funding For Breast Cancer

September 18, 1992

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000